_:na54543e75fd44724ad75d64298c539a2xb5
<http://schema.org/name>
<https://www.europeanpharmaceuticalreview.com/news/21063/onglyza-saxagliptin-demonstrates-no-increased-risk-for-cardiovascular-death-heart-attack-or-stroke-in-savor-cardiovascular-outcomes-trial/>